Skip to main content
Equibles

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1086619 London, X0
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,970,123
+$4,772,870 QoQ
Shares Held
187,017
+183.6% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 286 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. IDYA ranks #28 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 1,410,943 $99,683,122
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 169,270 $84,081,485
3 EXEL
Exelixis, Inc.
 669,005 $36,400,560
4 INSM
INSMED Inc
 298,372 $31,812,422
5 ALNY
Alnylam Pharmaceuticals, Inc.
 95,194 $28,656,248
6 MDGL
Madrigal Pharmaceuticals, Inc.
 51,630 $27,722,728
7 VERA
Vera Therapeutics, Inc.
 510,787 $21,917,869
8 TVTX
Travere Therapeutics, Inc.
 379,611 $21,565,700

All Filings in IDYA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,970,123 187,017
2026-03-31 $2,197,253 65,944
2025-12-31 $5,921,080 171,278
2025-09-30 $5,598,865 205,765
2025-06-30 $4,644,411 220,952
2025-03-31 $4,301,486 262,606
2024-12-31 $5,893,421 229,316
2024-09-30 $7,725,263 243,853
2024-06-30 $5,022,871 143,061
2024-03-31 $3,017,013 68,756